Sheridan Capital Partners invested in DAS Health Ventures, a provider of healthcare IT management solutions and services. In the transaction, Sheridan invested alongside DAS Health’s management, who retained an ownership stake in the business.
The transaction was led by Jonathan Lewis, Sean Dempsey, Chris McCrory and Addison Jones at Sheridan Capital Partners. Deerpath Capital Management provided debt financing for the transaction. McDermott Will & Emery served as legal counsel to Sheridan Capital Partners. Clearsight Advisors, Marcum and Hill Ward Henderson served as financial advisor, tax counsel and legal counsel, respectively. Financial terms of the transaction were not disclosed.
“We are thrilled to be partnering with Sheridan to expand and enhance our current position in the healthcare and managed IT realm. We are constantly working towards providing additional benefits for all clients, and Sheridan’s investment allows us to accomplish this goal at an accelerated rate,” David Schlaifer, president and CEO of DAS Health, said.
“Our partnership with DAS Health allows us to continue our strategy of supporting and augmenting entrepreneurs’ growth plans. The team at DAS has done an extraordinary job at improving efficiencies and productivity for their clients while scaling their own business and expanding the breadth of service capabilities and product offerings,” Jonathan Lewis, a partner at Sheridan Capital Partners, said. “We are elated to partner with DAS Health in this next chapter of their growth.”
